| Literature DB >> 28644413 |
Elena Ojer-Usoz1, David González2, Ana Isabel Vitas3.
Abstract
This study presents a comprehensive approach of a clonal diversity analysis of 448 Extended-spectrum β-lactamase (ESBL)-producing E. coli isolated from environmental, human and food samples in Spain. The phenotypic confirmation of ESBL production was performed by disc diffusion and microdilution methods, while Polymerase Chain Reaction (PCR) and sequencing were used for the molecular characterization of β-lactamase genes (blaCTX-M, blaSHV, blaTEM, blaOXA). Clonal relationship of isolates was determined by multi-locus sequence typing (MLST). Multidrug resistant strains were present in all the studied niches, with percentages above 50.0%. The most prevalent β-lactamase genes were blaCTXM-14 (26%) and blaCTXM-1 (21.4%), followed by blaSHV-12, blaCTX-M-15 and blaTEM-42. MLST isolates were grouped into 26 clonal complexes (CC) and 177 different sequence types (ST) were detected. Despite the high clonal diversity observed, CC10 was the prevalent and the only CC detected in all niches, while other complexes as CC131 were mainly associated to human isolates. The observed prevalence and diversity of these resistant bacteria across the different environments encourages a One Health approach to prevent and control ESBL dissemination between environment and consumers.Entities:
Keywords: ESBL-producing E. coli; MLST; clonal diversity; β-lactamase genes
Mesh:
Substances:
Year: 2017 PMID: 28644413 PMCID: PMC5551114 DOI: 10.3390/ijerph14070676
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Prevalence of ESBL-producing bacteria in the analyzed samples.
| Source | No. of Analyzed Samples | No. of Positive Samples (%) | No. of ESBL-Producing | No. of ESBL-Producing | No. of ESBL-Producing |
|---|---|---|---|---|---|
| Fresh meat | 169 | 96 (56.8) | 183 | 175 | 149 |
| Vegetables | 306 | 14 (4.6) | 11 | 4 | 1 |
| Fish | 37 | 1 (2.7) | 1 | 0 | 0 |
| Cooked meat | 34 | 1 (2.7) | 1 | 0 | 0 |
| Cheese | 34 | 0 | 0 | 0 | 0 |
| WWTP | 279 | 163 (58.4) | 163 | 132 | 117 |
| Rivers | 222 | 45 (20.3) | 41 | 30 | 26 |
| Farms | 91 | 47 (51.6) | 48 | 46 | 43 |
| - | - | - |
a Only E. coli isolates were provided by the Clinica Universidad de Navarra.
Percentages of resistance against different antimicrobials according to isolates origin.
| Antibiotic | Origin of Strains | ||||
|---|---|---|---|---|---|
| Food | WWTP | Rivers | Farms | Human | |
| AMP | 100.0 | 100.0 | 100.0 | 100.0 | 99.2 |
| PIP | 99.5 | 100.0 | 100.0 | 100.0 | 99.2 |
| MZ | 98.5 | 100.0 | 100.0 | 100.0 | 99.2 |
| CZ | 99.5 | 100.0 | 100.0 | 100.0 | 97.7 |
| CXM | 99.1 | 100.0 | 100.0 | 100.0 | 96.9 |
| CPD | 99.5 | 100.0 | 100.0 | 100.0 | 96.2 |
| CTX | 97.1 | 97.9 | 100.0 | 100.0 | 96.2 |
| CAZ | 97.6 | 80.4 | 83.7 | 100.0 | 96.2 |
| FOX | 9.7 | 34.6 | 43.0 | 4.0 | 14.6 |
| FEP | 94.2 | 82.3 | 18.0 | 2.0 | 94.6 |
| AZT | 96.6 | 92.0 | 87.8 | 100.0 | 96.2 |
| AMC | 18.0 | 50.0 | 36.3 | 10.0 | 57.7 |
| AMS | 79.1 | 97.0 | 92.0 | 68.0 | 89.2 |
| TZP | 1.9 | 81.1 | 20.0 | 4.0 | 24.6 |
| ETP | 0.0 | 1.5 | 2.0 | 0.0 | 2.3 |
| MER | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 |
| IMP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| AK | 99.5 | 0.0 | 2.0 | 0.0 | 8.5 |
| GM | 10.7 | 16.7 | 8.0 | 8.0 | 21.5 |
| TO | 7.8 | 19.5 | 8.0 | 10.0 | 37.7 |
| LV | 50.0 | 38.2 | 18.0 | 44.0 | 70.8 |
| CIP | 56.8 | 41.6 | 20.0 | 46.0 | 72.3 |
| MXF | 67.0 | 52.3 | 33.0 | 58.0 | 75.4 |
| TET | 83.0 | 48.4 | 71.0 | 72.0 | 76.1 |
| TIG | 0.5 | 2.1 | 2.0 | 0.0 | 2.3 |
| COL | 21.8 | 0.0 | 24.0 | 10.0 | 27.7 |
| SXT | 40.8 | 38.0 | 27.0 | 34.0 | 65.4 |
| FOT | 2.9 | 11.9 | 22.0 | 2.0 | 4.6 |
| FM | 14.6 | 26.7 | 12.0 | 8.0 | 10.8 |
| CHL | 23.7 | 13.6 | 16.3 | 22.0 | 33.1 |
Ampicillin, AMP; piperacillin, PIP; mezlocillin, MZ; cefazolin, CZ; cefuroxime, CXM; cefpodoxime, CPD; cefotaxime, CTX; ceftazidime, CAZ, cefoxitin, FOX; cefepime, FEP; aztreonam, AZT; amoxicillin clavulanic acid, AMC; amoxicillin sulbactam, AMS; piperacillin tazobactam, TZP; ertapenem, ETP; meropenem, MER; imipenem, IMP; Amikacin, AK; gentamicin, GM; tobramycin, TO; levofloxacin, LV; ciprofloxacin, CIP; moxifloxacin, MXF; tetracycline, TET; tigecycline, TIG; colistin, COL; trimethoprim sulfamethoxazole, SXT; fosfomycin, FOT; nitrofurantoin, FM; chloramphenicol, CHL. MDR: multi drug resistance.
Genotypic characteristics of ESBL-producing E. coli isolated from different sources.
| Sample Origin | No. of ESBL-Producing | No. of | Percentages of Detected | ||||
|---|---|---|---|---|---|---|---|
| CTX-M-14 | CTX-M-1 | CTX-M-15 | TEM-42 | SHV-12 | |||
| Food | 179 | 150 | 25.0 | 23.9 | 1.2 | 12.5 | 18.5 |
| WWTP | 132 | 117 | 24.5 | 18.4 | 11.1 | 11.7 | 14.1 |
| Rivers | 30 | 26 | 17.1 | 24.4 | 9.8 | 4.9 | 9.8 |
| Farms | 46 | 43 | 15.5 | 28.1 | 21.4 | 16.7 | 51.0 |
| Human | 130 | 112 | 33.5 | 11.5 | 39.2 | 13.1 | 10.7 |
Figure 1Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according to ESBL genes (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Figure 2Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according samples’ origin (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Distribution of main Clonal Complexes (CC) detected in human, environmental, and food samples.
| Clonal Complex | Number of Isolates | ||||
|---|---|---|---|---|---|
| Food | WWTP | River | Farm | Human | |
| CC10 | 21 | 16 | 2 | 6 | 16 |
| CC101 | 2 | - | - | 5 | - |
| CC131 | 1 | - | - | - | 26 |
| CC155 | 6 | 6 | - | - | 1 |
| CC156 | 2 | 7 | - | - | 1 |
| CC168 | 4 | 3 | - | 1 | - |
| CC23 | - | 7 | - | 6 | 13 |
| CC350 | 1 | 1 | - | - | 1 |
| CC398 | - | 1 | - | - | 1 |
| CC448 | 1 | - | - | - | 2 |
| CC46 | 2 | 5 | 3 | - | 1 |
| CC648 | 6 | - | - | - | 5 |
| CC69 | - | 1 | - | - | 1 |
| CC86 | 5 | 1 | - | - | 3 |